Jade Biosciences, Inc. (JBIO)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 2 signals for Jade Biosciences, Inc.. Most notable: 2026-06-26: Filed 8-K disclosing director or officer change; 2026-07-01: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-12 | Dahms Bradford D. | officer | A | 37,813 | 0 | $0 |
| 2026-02-12 | Balta Elizabeth | officer | A | 28,125 | 0 | $0 |
| 2026-02-12 | Frohlich Tom | director | A | 78,750 | 0 | $0 |
| 2026-02-12 | King Andrew James | officer | A | 41,250 | 0 | $0 |
| 2026-02-12 | Dahms Bradford D. | officer | A | 37,813 | 0 | $0 |
| 2026-02-12 | Balta Elizabeth | officer | A | 28,125 | 0 | $0 |
| 2026-02-12 | Frohlich Tom | director | A | 78,750 | 0 | $0 |
| 2026-02-12 | King Andrew James | officer | A | 41,250 | 0 | $0 |
| 2025-10-06 | Fairmount Healthcare Fund II L.P. | director | A | 1,333,126 | 9.14 | $12,184,772 |
| 2025-10-06 | Fairmount Funds Management LLC; Fairmount Healthcare Fund II L.P.; Fairmount Healthcare Co-Invest IV L.P.; Kiselak Tomas; Harwin Peter Evan | director | A | 1,333,126 | 9.14 | $12,184,772 |
| 2025-05-16 | Frohlich Tom | director | P | 6,000 | 7.4 | $44,400 |
| 2025-05-16 | Frohlich Tom | director | P | 6,000 | 7.4 | $44,400 |
| 2025-04-28 | Kolchinsky Peter | ten percent owner | J | 1,062,326 | — | — |
| 2025-04-28 | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. | ten percent owner | J | 1,062,326 | — | — |
| 2024-08-01 | Dake Benjamin T | officer | M | 1,507 | 1.74 | $2,622 |
| 2024-08-01 | Dake Benjamin T | officer | M | 1,507 | 1.74 | $2,622 |
| 2024-07-31 | Dake Benjamin T | officer | M | 11,454 | 1.74 | $19,930 |
| 2024-07-31 | Dake Benjamin T | officer | M | 11,454 | 1.74 | $19,930 |
| 2024-06-17 | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; Shah Rajeev M. | director | P | 928,110 | 1.67 | $1,549,944 |
| 2024-06-14 | Eldridge George A | officer | M | 15,000 | 2.14 | $32,100 |
| 2024-06-14 | Eldridge George A | officer | S | 15,000 | 25.03 | $375,450 |
| 2024-06-14 | Verwijs Marinus | officer | M | 10,600 | 14.59 | $154,654 |
| 2024-06-14 | Verwijs Marinus | officer | S | 10,600 | 25 | $265,000 |
| 2024-06-13 | Gillies Hunter | officer | M | 6,000 | 2.14 | $12,840 |
| 2024-06-13 | Gillies Hunter | officer | S | 6,000 | 24.5 | $147,000 |
| 2024-05-17 | Gillies Hunter | officer | M | 4,000 | 2.14 | $8,560 |
| 2024-05-17 | Gillies Hunter | officer | S | 3,914 | 21.07 | $82,452 |
| 2024-05-17 | Gillies Hunter | officer | S | 86 | 21.86 | $1,880 |
| 2024-05-16 | NOYES TIMOTHY P | director | M | 10,000 | 2.14 | $21,400 |
| 2024-05-16 | NOYES TIMOTHY P | director | S | 8,707 | 21.52 | $187,410 |
| 2024-05-16 | NOYES TIMOTHY P | director | S | 1,293 | 21.92 | $28,345 |
| 2024-05-02 | Verwijs Marinus | officer | S | 1,981 | 21.02 | $41,631 |
| 2024-05-01 | NOYES TIMOTHY P | director | M | 10,000 | 2.14 | $21,400 |
| 2024-05-01 | NOYES TIMOTHY P | director | S | 9,035 | 20.34 | $183,793 |
| 2024-05-01 | NOYES TIMOTHY P | director | S | 965 | 20.87 | $20,135 |
| 2024-05-01 | NOYES TIMOTHY P | director | S | 1,357 | 19.91 | $27,018 |
| 2024-04-17 | Dake Benjamin T | officer | M | 6,853 | 2.14 | $14,665 |
| 2024-04-17 | Dake Benjamin T | officer | S | 6,447 | 22.32 | $143,865 |
| 2024-04-17 | Dake Benjamin T | officer | S | 338 | 23.17 | $7,831 |
| 2024-04-17 | Dake Benjamin T | officer | S | 68 | 23.97 | $1,630 |
| 2024-04-17 | Gillies Hunter | officer | M | 4,000 | 1.74 | $6,960 |
| 2024-04-17 | Gillies Hunter | officer | S | 3,689 | 22.3 | $82,267 |
| 2024-04-17 | Gillies Hunter | officer | S | 311 | 23.33 | $7,255 |
| 2024-04-16 | NOYES TIMOTHY P | director | M | 10,000 | 2.14 | $21,400 |
| 2024-04-16 | NOYES TIMOTHY P | director | S | 4,491 | 24.4 | $109,561 |
| 2024-04-16 | NOYES TIMOTHY P | director | S | 5,509 | 24.94 | $137,410 |
| 2024-04-10 | Eldridge George A | officer | M | 7,500 | 2.14 | $16,050 |
| 2024-04-10 | Eldridge George A | officer | S | 6,729 | 26.77 | $180,139 |
| 2024-04-10 | Eldridge George A | officer | S | 771 | 27.56 | $21,252 |
| 2024-04-09 | GRAYZEL DAVID S. | director | S | 11,882 | 28.15 | $334,478 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-10 10-Q
- 2026-08-10 8-K
- 2026-07-17 SCHEDULE 13G
- 2026-07-08 SCHEDULE 13G/A
- 2026-07-01 8-K
- 2026-06-26 4
- 2026-06-26 3
- 2026-06-26 8-K
- 2026-06-11 4
- 2026-06-11 4
- 2026-06-11 4
- 2026-06-11 4
- 2026-06-11 4
- 2026-06-11 8-K
- 2026-06-09 SCHEDULE 13D/A
- 2026-06-05 DEFA14A
- 2026-06-04 8-K
- 2026-06-04 424B5